Third Security buys $3.9 Million stake in Transgenomic Inc (TBIO)

Transgenomic Inc (TBIO) : Third Security scooped up 6,780,179 additional shares in Transgenomic Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 11, 2016. The investment management firm now holds a total of 7,550,669 shares of Transgenomic Inc which is valued at $3.9 Million.Transgenomic Inc makes up approximately 0.20% of Third Security’s portfolio.

Other Hedge Funds, Including , White Pine Capital reduced its stake in TBIO by selling 91,358 shares or 26.96% in the most recent quarter. The Hedge Fund company now holds 247,479 shares of TBIO which is valued at $128,442. Transgenomic Inc makes up approx 0.06% of White Pine Capital’s portfolio.Blackrock Fund Advisors boosted its stake in TBIO in the latest quarter, The investment management firm added 462 additional shares and now holds a total of 2,605 shares of Transgenomic Inc which is valued at $1,352.Cambridge Investment Research Advisors boosted its stake in TBIO in the latest quarter, The investment management firm added 79,273 additional shares and now holds a total of 113,900 shares of Transgenomic Inc which is valued at $56,950.

Transgenomic Inc opened for trading at $0.65 and hit $0.65 on the upside on Monday, eventually ending the session at $0.64, with a gain of 23.31% or 0.121 points. The heightened volatility saw the trading volume jump to 2,72,272 shares. Company has a market cap of $13 M.

Transgenomic Inc. (Transgenomic) is a global biotechnology company advancing personalized medicine for the detection and treatment of cancer and inherited diseases. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market. The Company operates through two segments: Laboratory Services and Genetic Assays and Platforms. The Company’s laboratories are engaged in genetic testing for cardiology neurology and mitochondrial disorders and for oncology. It has Patient Testing laboratories in New Haven Connecticut and Omaha Nebraska and a Biomarker Identification laboratory in Omaha. Its product offering WAVE System is offered for genetic variation detection in both molecular genetic research and molecular diagnostics. It also distributes bio-instruments produced by other manufacturers (OEM Equipment) through its sales and distribution network. It manufactures and sells consumable products including chromatography columns.

Leave a Reply

Transgenomic Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Transgenomic Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.